WO2020101858A1 - Source de neutrons pour thérapie par capture de neutrons - Google Patents

Source de neutrons pour thérapie par capture de neutrons Download PDF

Info

Publication number
WO2020101858A1
WO2020101858A1 PCT/US2019/057884 US2019057884W WO2020101858A1 WO 2020101858 A1 WO2020101858 A1 WO 2020101858A1 US 2019057884 W US2019057884 W US 2019057884W WO 2020101858 A1 WO2020101858 A1 WO 2020101858A1
Authority
WO
WIPO (PCT)
Prior art keywords
moderator
chamber
neutron
acceleration chamber
block
Prior art date
Application number
PCT/US2019/057884
Other languages
English (en)
Inventor
Melvin Arthur Piestrup
Craig Mathew Brown
Allan Xi CHEN
Charles Kevin GARY
Yao Zong GUAN
Yoshio Horii
Glenn Emerson JONES JR.
Yuji Kokubo
Naoyuki Yamada
Shotaro Komura
Original Assignee
Adelphi Technology, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adelphi Technology, Inc. filed Critical Adelphi Technology, Inc.
Priority to EP19885945.6A priority Critical patent/EP3870283A4/fr
Priority to EP22204108.9A priority patent/EP4147750B1/fr
Priority to JP2021547657A priority patent/JP7126733B2/ja
Priority claimed from US16/662,523 external-priority patent/US10737121B2/en
Publication of WO2020101858A1 publication Critical patent/WO2020101858A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1077—Beam delivery systems
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H3/00—Production or acceleration of neutral particle beams, e.g. molecular or atomic beams
    • H05H3/06—Generating neutron beams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/109—Neutrons
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
    • H05H2277/00—Applications of particle accelerators
    • H05H2277/10—Medical devices
    • H05H2277/11—Radiotherapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E30/00—Energy generation of nuclear origin
    • Y02E30/10—Nuclear fusion reactors

Definitions

  • This invention is in the technical area of apparatus and methods for Boron Neutron capture therapy for cancer.
  • BNCT Boron Neutron Capture Therapy
  • neutrons interact with boron- 10 that has been placed at the cancer site.
  • the neutrons interact with the boron to produce fission events whereby alpha particles and lithium nuclei are created. These massive ionized particles are then released, destroying the chemical bonds of nearby cancer tumor cells.
  • the neutrons created in a reactor or accelerator pass through a moderator, which shapes the neutron energy spectrum suitable for BNCT treatment. While passing through the moderator and then the tissue of the patient, the neutrons are slowed by collisions and become low energy thermal neutrons.
  • the thermal neutrons undergo reactions with the boron- 10 nuclei at a cancer site, forming compound nuclei (excited boron- 11), which then promptly disintegrate to lithium-7 and an alpha particle. Both the alpha particle and the lithium ion produce closely spaced ionizations in the immediate vicinity of the reaction, with a range of approximately 5-9 micrometers, or roughly the thickness of one cell diameter. The release of this energy destroys surrounding cancer cells. This technique is advantageous since the radiation damage occurs over a short range and thus normal tissues can be spared.
  • Gadolinium can also be considered as a capture agent in neutron capture therapy (NCT) because of its very high neutron capture cross section.
  • NCT neutron capture therapy
  • a number of gadolinium compounds have been used routinely as contrast agents for imaging brain tumors. The tumors have absorbed a large fraction of the gadolinium, making gadolinium an excellent capture agent for NCT. Therefore, GNTC may also be considered as a variation in embodiments of the present invention.
  • E neutron energy ranges
  • BNCT glioblastoma multiforme
  • liver cancers For distributed tumors, effective radiation therapy must encompass a larger volume and the radiation must be uniformly distributed. This is also true of liver cancers.
  • the liver is the most common target of metastases from many primary tumors. Primary and metastatic liver cancers are usually fatal, especially after resection of multiple individual tumors. The response rate for nonresectable hepatocellular carcinoma to traditional radiation treatment or chemotherapy is also very poor.
  • recent results indicate that the thermal neutron irradiation of the whole liver with a 10 B compound, to be bombarded with low-energy neutrons, could be a way to destroy all the liver metastases.
  • BNCT neutron capture therapy
  • BNCT has been found to be effective and safe in the treatment of inoperable, locally advanced head and neck carcinomas that recur at sites that were previously irradiated with traditional gamma radiation.
  • BNCT could be considered for a wider range of cancers.
  • BNCT holds such promise because the dose to the cancer site can be greatly enhanced over that produced by g- radiation sources. This is a consequence of the fact that the neutron-boron reaction produces the emission of short-range (5-9 um distance) radiation, and consequently normal tissues can be spared.
  • boron can achieve a high tumor-to-brain concentration ratio, as much as ten or more, thereby preferentially destroying abnormal tissue.
  • BNCT has been tested using either nuclear reactors or accelerators to produce the neutrons, which are not practical or affordable for most clinical settings. Reactors also do not produce an ideal neutron spectrum and are contaminated with g-radiation.
  • Fusion generators produce fast neutrons from the deuterium-deuterium (DD) or the deuterium-tritium (DT) reactions and are, in general, smaller and less expensive than accelerators and reactors. Fast neutrons thus produced must be moderated or slowed down to thermal or epithermal neutron energies using, for example, water or other hydrogen bearing materials.
  • the fusion neutron generator has three basic components: an ion source, an electron shield and an acceleration structure with a target.
  • the ions are accelerated from the ion source to usually a titanium target using a high voltage potential of between 40 kV to 200 kV, which can be easily delivered by a modem high voltage power supply.
  • An electron shield is usually disposed between the ion source and the titanium target. This shield is voltage biased to repel electrons being generated when the positive D+ ions that strike the titanium target. This prevents these electrons from striking the ion source and damaging it due to electron heating.
  • the target uses a deuterium D + or tritium T + absorbing material such as titanium, which readily absorbs the D + or T + ions, forming a titanium hydride. Succeeding D + or T + ions strike these embedded ions and fuse, resulting in DD, DT or TT reactions and releasing fast neutrons.
  • a deuterium D + or tritium T + absorbing material such as titanium, which readily absorbs the D + or T + ions, forming a titanium hydride. Succeeding D + or T + ions strike these embedded ions and fuse, resulting in DD, DT or TT reactions and releasing fast neutrons.
  • the planar neutron irradiation system leads to a high surface or skin dosage and a decreasing neutron dose deeper into the brain.
  • the brain is not irradiated uniformly, and cancer sites have lower thermal neutron dosage the further they are from the planar port.
  • FIG. 1 A conventional planar neutron irradiation system 14 and its operation is shown in Fig. 1 labeled Prior Art.
  • Conversion of fast neutrons 22 to thermal neutrons 30 takes place in a series of steps.
  • First the fast neutrons 22 are produced by a cylindrical fast neutron generator 20 and then enter a moderating means 18 where they suffer elastic scatterings (collisions with nuclei of the moderating material’s atoms). This lowers the fast neutrons to epithermal neutron 24 energies.
  • a mixture of epithermals 24 and thermal neutrons 30 are emitted out of a planar port 16 and then enter the patient’ s head 26.
  • the epithermal neutrons 24 are moderated still further in the patient’s brain and moderated further to thermal neutrons, finally being captured by the boron at the tumor site.
  • the fission reaction occurs, and alpha and Li-7 ions are released, destroying the tumor cells.
  • the epithermal and thermal neutrons reach the patient's head through a planar port 16 formed from neutron absorbing materials that form a collimating means 28.
  • the thermal and epithermal neutrons strike the patient’s head on one side, and many neutrons escape or are not used.
  • One escaping neutron 38 is shown as representative. This is an inefficient process requiring a large number of fast neutrons to be produced in order to produce enough thermal neutrons for reasonable therapy or treatment times (e.g. 30 min).
  • planar neutron irradiation system 14 requires that one use either the DD fusion reaction with extremely high acceleration powers (e.g. 0.5 to 1.5 Megawatts) or the DT reaction which has an approximate 100-fold increase in neutron yield for the same acceleration power.
  • Tritium gas is radioactive and extremely difficult to eliminate once it gets on to a surface. In the art of producing fast neutrons this requires that the generator be sealed and have a means for achieving a vacuum that is completely sealed.
  • the generator head cannot be easily maintained and usually its lifetime is limited to less than 2000 hours. This reduces the possible use of this generator for clinical operation since the number of patients who could be treated would be small before the generator head would need replacement.
  • the use of the DD fusion reaction allows one skilled in the art to use an actively-pumped- vacuum means with roughing and turbo pumps. The generator can then be opened for repairs and its lifetime extended. This makes the DD fusion reaction neutron generator optimum for clinical use.
  • the downside for the DD fusion reaction is that high acceleration powers are required to achieve the desired neutron yield required by prior art methods. Improving the efficiency of producing the right thermal neutron flux at the cancer site is imperative for achieving BNCT in a clinical and hospital setting.
  • a neutron generator comprising a pre-moderator block of moderating material having an upper surface, a lower surface, a first and a second end, first and second side surfaces, a first length, a first width substantially less than the first length, and a first thickness, a cylindrical acceleration chamber having a first diameter substantially the first width of the pre moderator block, sealed at one end to the upper surface of the pre-moderator block adjacent the first end of the pre-moderator block, with a vertical axis perpendicular to the upper surface, the acceleration chamber having a height and a top cover at a second end away from the pre-moderator block, a vacuum pump engaging the acceleration chamber, evacuating the acceleration chamber to a moderately high vacuum, a plasma ion chamber opening into the acceleration chamber through an ion extraction iris through the top cover of the acceleration chamber on the vertical axis of the acceleration chamber, a gas source providing deuterium gas to the plasma ion chamber, a microwave energy source
  • Ions extracted through the ion extraction iris are accelerated to bombard the titanium target at the lower extremity of the primary isolation well, producing energetic neutrons that pass through and are moderated by the pre-moderator block, and wherein any path along a surface of the from the titanium target to an electrically grounded element is necessarily maximized by the primary and secondary isolation wells.
  • the material of the pre-moderator block is Ultra- High- Molecular- Weight Polyethylene (UHMWPE or UHMW), or High-Density
  • the generator further comprises supply and return water channels lengthwise through the pre-moderator block from the second end of the pre-moderator block to the titanium target, providing cooling water cooling the target.
  • the neutron generator further comprises a female socket for a high-voltage male connector at the second end of the pre-moderator block, coupled to a high-voltage bus bar implemented lengthwise through the pre-moderator block, to the target, for biasing the target to a substantial negative DC voltage.
  • both the first and second side surfaces of the pre-moderator block are angled inward from vertical by thirty degrees for at least a portion of the height, enabling six neutron generators to be placed with the angled side surfaces fully adjacent, forming a closed ring about a center point.
  • both the first and second side surfaces of the pre-moderator block are angled inward from vertical by forty-five degrees for at least a portion of the height, enabling eight neutron generators to be placed with the angled side surfaces fully adjacent, forming a closed ring about a center point.
  • a boron neutron cancer treatment system comprising a secondary moderator having a central treatment chamber for a subject, and six substantially identical neutron generators, each comprising a pre moderator block of moderating material having an upper surface, a lower surface, a first and a second end, opposite side surfaces angled inward by thirty degrees along at least a portion of the height, a first length, a first width substantially less than the first length, and a first thickness, a cylindrical acceleration chamber having a first diameter substantially the first width of the pre-moderator block, sealed at one end to the upper surface of the pre-moderator block adjacent the first end of the pre- moderator block, with a vertical axis perpendicular to the upper surface, the acceleration chamber having a height and a top cover at a second end away from the pre-moderator block, a vacuum pump engaging the acceleration chamber at a right angle to the vertical axis, evacuating the acceleration chamber to a moderately high vacuum, a
  • the system further comprises six substantially rectangular spacing blocks of moderator material, one spacing block placed between each adjacent neutron generator with sides of the spacing blocks fully adjacent with the angled sides of the neutron generators.
  • the secondary moderator is shaped to fill all volume between the neutron generators and the central treatment chamber.
  • the secondary moderator is a block or blocks of solid moderator material.
  • the secondary moderator is a container filled with heavy water.
  • the secondary moderator is a container filled with granulated moderator material.
  • a boron neutron cancer treatment system comprising a secondary moderator having a central treatment chamber for a subject, and eight substantially identical neutron generators, each comprising a pre moderator block of moderating material having an upper surface, a lower surface, a first and a second end, opposite side surfaces angled inward by forty-five degrees along at least a portion of the height, a first length, a first width substantially less than the first length, and a first thickness, a cylindrical acceleration chamber having a first diameter substantially the first width of the pre-moderator block, sealed at one end to the upper surface of the pre- moderator block adjacent the first end of the pre moderator block, with a vertical axis perpendicular to the upper surface, the acceleration chamber having a height and a top cover at a second end away from the pre-moderator block, a vacuum pump engaging the acceleration chamber at a right angle to the vertical axis, evacuating the acceleration chamber to a moderately high vacuum,
  • this system further comprises eight substantially rectangular spacing blocks of moderator material, one spacing block placed between each adjacent neutron generator with sides of the spacing blocks fully adjacent with the angled sides of the neutron generators.
  • the secondary moderator is shaped to fill all volume between the neutron generators and the central treatment chamber.
  • the secondary moderator is a block or blocks of solid moderator material.
  • the secondary moderator is a container filled with heavy water.
  • the secondary moderator is a container filled with granulated moderator material.
  • a treatment system for evaluating boron sources for boron neutron cancer therapy comprising a substantially square secondary moderator having a central treatment chamber for a subject, and four substantially identical neutron generators, each comprising a pre moderator block of moderating material having an upper surface, a lower surface, a first and a second end, opposite parallel side surfaces, a first length, a first width substantially less than the first length, and a first thickness, a cylindrical acceleration chamber having a first diameter substantially the first width of the pre-moderator block, sealed at one end to the upper surface of the pre-moderator block adjacent the first end of the pre-moderator block, with a vertical axis perpendicular to the upper surface, the acceleration chamber having a height and a top cover at a second end away from the pre-moderator block, a vacuum pump engaging the acceleration chamber at a right angle to the vertical axis, evacuating the acceleration chamber to a moderately high vacuum,
  • the secondary moderator is a block or blocks of solid moderator material. In one embodiment the secondary moderator is a container filled with heavy water. And in one embodiment the secondary moderator is a container filled with granulated moderator material.
  • a Boron neutron cancer treatment system comprising a moderator chamber filled with liquid or granular moderator material except for a central treatment chamber, the moderator chamber having parallel upper and lower surfaces, a plurality of neutron generators, each comprising a pre-moderator block of moderating material having an upper surface, a lower surface, a first and a second end, opposite side surfaces, a first length, a first width substantially less than the first length, and a first thickness, a cylindrical acceleration chamber having a first diameter substantially the first width of the pre- moderator block, sealed at one end to the upper surface of the pre-moderator block adjacent the first end of the pre-moderator block, with a vertical axis perpendicular to the upper surface, the acceleration chamber having a height and a top cover at a second end away from the pre-moderator block, a vacuum pump engaging the acceleration chamber, evacuating the acceleration chamber to a moderately high vacuum, a plasma ion
  • Fig. 1 is a cross sectional view of a planar geometry for introducing thermal neutrons into a patient's brain.
  • Fig. 2 is a cross sectional view of an embodiment of how multiple fast neutron generators are arranged around a hemispheric moderator to introduce a uniform thermal neutron dose into a patient’ s head.
  • Fig. 3 is a perspective view of how multiple fast neutron generators are used in an embodiment of the invention to develop a high neutron dose into a patient’ s head.
  • Fig. 4 is a cross sectional view of the arrangement of Fig 3 with the patient’ s head inside the interior of the neutron irradiation system.
  • Fig. 5 is a graph of the dose rate (Gy-equivalent/hr) as a function of distance from the surface of the head (skin) for the planar and hemispheric moderator (radial source) geometries.
  • Fig. 6 is a graph of the therapeutic ratio as a function of distance from the surface of the head (skin) for the hemispheric (radial source) and planar moderator geometries in an embodiment of the invention.
  • Fig. 7A is a cross sectional view of an embodiment of a cylindrical neutron irradiation system for the liver and other organs of the body.
  • Fig. 7B is a perspective view of the cylindrical neutron irradiation system for the liver and other organs of a body.
  • Fig. 8 is a cross sectional view of one of the embodiments of a neutron irradiation system wherein the neutron generators can be controlled independently to maximize thermal neutron flux at the liver or other organ of a body.
  • Fig. 9 is a simplified view of the cross section of the irradiation system that uses neutron generators that can be controlled independently of one another.
  • Fig. 10 is a graph of the therapeutic ratio as a function of distance along the axis of the liver in cm.
  • Fig. 11 is a graph of the dose rate as a function of distance along the axis of the liver in cm.
  • Fig. 12A is a perspective view of a modular neutron generator in an embodiment of the invention.
  • Fig. 12 B is a perspective cross-section view of the module of Fig. 12A taken along an axis of the acceleration chamber, at a right angle to an axis of the turbo vacuum pump.
  • Fig. 12 C is a perspective cross-section view of the module of Fig. 12A taken along an axis of the turbo vacuum pump.
  • Fig. 13 A is a planar view of six modular generators arrayed around a moderator and chamber for a patient, in an embodiment of the invention.
  • Fig. 13 B is a perspective view of the system of Fig. 13 using six modular neutron generators in an embodiment of the invention.
  • Fig. 13 C is a perspective view of a cylindrical neutron irradiation system using eight modular generators with one removed to show how an irradiation system is assembled in an embodiment of the invention.
  • Fig. 13 D is a planar diagram of modular generators with a fluid moderator and arrayed to maximize dose to a cancer site in a brain, in an embodiment of the invention.
  • Fig. 14 A is a simplified, mostly diagrammatical view of a central cylinder with a human head (phantom) inside a helmet moderator and neutron reflector with eight modular neutron generators in an embodiment of the invention.
  • Fig. 14B is a simplified, mostly diagrammatical section view taken along section line 14B-14B of Fig. 14A.
  • Fig. 15 is a graph showing an expected horizontal dose equivalent rate (Sv/hr) as a function of horizontal position across a phantom (head) in an embodiment of the invention.
  • Fig. 16A is a perspective view of a module for a small animal neutron radiation system employing four modules.
  • Fig. 16B is a simplified top plan view of the small animal neutron irradiation system of Fig. 16A.
  • Fig. 16C is a simplified cross section of the small animal neutron irradiation system of Fig. 16A.
  • Fig. 16D is an exploded plan view of the small animal neutron irradiation system of Fig. 16A. DETAILED DESCRIPTION
  • a hemispherical geometry is used in one embodiment of the invention.
  • This unique geometry arranges fast neutron sources in a circle around a moderator whose radial thickness is optimized to deliver a maximum thermal neutron flux to a patient's brain.
  • This embodiment produces a uniform thermal neutron dose within a factor of 1 /20 th of the required fast neutron yield and line- voltage input power of a conventional planar neutron irradiation system.
  • This arrangement permits using a relatively safe deuterium-deuterium (DD) fusion reaction (no radioactive tritium) and commercial high voltage power supplies operating at modest powers (50 to 100 kW).
  • DD deuterium-deuterium
  • Fig. 2 is a cross sectional view of a hemispheric neutron irradiation system 36 according to one embodiment of the invention.
  • Multiple fast neutron generators 68 surround a hemispheric moderator 34, which in turn surrounds the patient’s head 26. Titanium targets 52 are distributed around the perimeter of the hemispheric moderator 34. Surrounding the moderator 34 and the fast neutron generators 68 is a fast-neutron reflector 44.
  • moderating material such as 7 LiF, high density polyethylene (HDPE), and heavy water are shaped in a hemisphere that is shaped around the head of the patient.
  • the optimum thickness of the hemispheric moderator for irradiation purposes is dependent upon the material’s nuclear structure and density.
  • Fig. 3 shows a perspective view of a patient 58 on a table 54 with the patient's head inserted into hemispheric irradiation system 36.
  • the patent 58 lies on the table 54 with his head inserted into hemispheric moderator 34.
  • neutron reflecting material 44 such as lead or bismuth.
  • fast neutrons 22 are produced by fast neutron generators 68.
  • Generators 68 are composed of titanium targets 52 and ion sources 50. Ion beams are produced by ion sources 50 and accelerated toward titanium targets 52 which are embedded in hemispheric moderator 34. A DD fusion reaction occurs at the target, producing 2.5 MeV fast neutrons 22.
  • the fast neutrons 22 enter the moderator 34 wherein they are elastically scattered by collisions with the moderator atom’s nuclei. This slows them down after a few collisions to epithermal neutrons 24 energies. These epithermal neutrons 24 enter the patient’s head 26 wherein they are moderated further to thermal neutron 30 energies. These thermal neutrons 30 are then captured by boron- 10 nuclei at the cancer site, resulting in a fusion event and the death of proximal cancer cells.
  • Fast neutrons 22 are emitted isotropically from titanium target 52 in all directions. Outwardly traveling fast neutrons 42 are reflected back (reflected neutron 48) by fast neutron reflector 44, while inwardly traveling fast neutrons 40 are moderated to epithermal energies and enter the patient’s head 26, where further moderation of the neutrons to thermal energies occurs.
  • a shell of protective shielding 56 is also shown in Fig. 2. In some embodiments, this may be necessary for shielding both the patient and the operator from excessive irradiation due to neutrons, x-rays and gamma radiation.
  • the shielding can be made of a variety of materials depending upon the radiation components one wishes to suppress.
  • fast neutron reflector 44 is made of lead or bismuth.
  • the fast neutron reflector also acts as a shielding means to reduce emitted gamma rays and neutrons from the hemispherical neutron irradiation system 36.
  • gamma-absorbing or other neutron reflector means can be placed in layers around the hemispherical neutron irradiation system 36 to reduce spurious and dangerous radiation from reaching the patient 58 and the operator.
  • Hemispheric moderator 34, fast neutron reflector 44 and head 26 act together to concentrate the thermal neutrons in the patient’s head.
  • the patent’s head and the moderator 34 act in concert as a single moderator. With a careful selection of moderating materials and geometry, a uniform dose of thermal neutrons can be achieved across the patient’s head and, if a boron drug is administered, a large and uniform therapeutic ratio can be achieved.
  • the invention gives a uniform dose of thermal neutrons to the head while minimizing the fast neutron and gamma contributions.
  • the required quantity of fast neutrons to initiate this performance is reduced compared to that of prior art planar neutron irradiation systems (see Fig. 1).
  • FIG. 4 A cross section perspective view of the hemispheric neutron irradiation system 36 in an embodiment of the invention is shown in Fig. 4.
  • This cross-section view is of a radial cut directly through the patent’s head 26 and hemispherical neutron irradiation system 36.
  • ten fast-neutron generators 68 composed of ion sources 50 with titanium targets 52 are radially surrounding the hemispheric moderator 34 and the patient’s head 26.
  • the titanium target 52 in this embodiment is a continuous belt of titanium surrounding the moderator 34.
  • the titanium targets can also be segmented, as was shown in Fig. 2.
  • the ion sources in this embodiment are embedded in fast neutron reflector 44.
  • the combined fast neutron yield striking the area from all the fast neutron generators 68 is assumed in the MCNP to be 10 11 n/s.
  • the optimum thickness, range of thicknesses and maximum thermal neutron flux (E ⁇ 0.5 eV) are given in Table I for various moderator materials. These are approximate values given to help determine the general dimensions of the moderator.
  • the calculation of the therapeutic ratio is also important and depends upon the organ in question (brain, liver) and the body mass of the patient. Although HDPE gives the highest flux, it gives a lower therapeutic ratio compared to 7 LiF. The designer is expected to do calculations similar to this to determine the optimum geometry for the neutron irradiation system.
  • the head is assumed to be 28 cm by 34 cm.
  • Fast neutron generators 68 are assumed to emit a total yield of 10 11 n/sec.
  • the combined titanium targets 52 give a total neutron emission area of 1401 cm 2 .
  • BPA Bactephrine
  • the concentration of boron in the tumor was 68.3 pg/gm and in the healthy tissue was 19 pg/gm.
  • the calculated neutron dose rates in Gy-equivalent/hr are plotted in Fig. 5 as a function of distance from the skin to the center of the head. The calculated dose rates are comparable to those used for gamma radiotherapy, typically 1.8 to 2.0 Gy per session. For the same dosage, at a rate of 3 Gy-equivalent/hr, the session length would be from 30 to 40 min. long. These session times are considered reasonable for a patient to undergo.
  • the therapeutic ratio for the hemispherical neutron irradiation system is plotted in Fig. 6 as a function of distance from the skin to the center of the skull.
  • the therapeutic ratio is defined as the delivered tumor dose divided by the maximum dose to healthy tissue.
  • a therapeutic ratio of greater than 3 is considered adequate for cancer therapy.
  • the conventional planar neutron irradiation system requires larger fast-neutron yields (10 12 to 10 13 n/s) to achieve equivalent dose rates and therapeutic ratios.
  • a planar neutron irradiation system 14 of Fig. 1 is compared with that of a hemispheric neutron irradiation system 36 (Figs. 2, 3, 4) in one embodiment of the present invention, using the same source of fast neutrons (10 11 n/s).
  • the hemispherical neutron irradiation system (called radial source in Figs. 5) achieves a dose rate of about a factor of 20 over that of the conventional planar neutron irradiation system 14.
  • planar geometry needs a fast neutron source of 2 x 10 12 n/s to achieve the same results. Indeed, if a DD fusion generator is used, then the planar source requires a factor of 20 X increase in wall-plug power or 2.0 MW, a prohibitively large power requirement.
  • hemispheric neutron irradiation system 36 has less than a 10% variation in dosage.
  • a uniform dose rate is crucial for the treatment of GBM, where we want to maintain a maximum therapeutic ratio and tumors may have distributed themselves across the brain.
  • Hemispherical neutron radiation system 36 in embodiments of the invention also gives a more uniform therapeutic ratio (Fig. 6) across the brain.
  • the ratio is more uniform for the radial source and requires only l/20 th of the fast neutron yield of the planar source (Fig. 1).
  • hemispheric moderator 34 Other materials can be used for hemispheric moderator 34 in alternative embodiments. As those skilled in the art will know, high density polyethylene (HDPE), heavy water (D2O), Graphite and 7 LiF can also be used. In addition, combinations of materials (e.g. 40% A1 and 60% AIF3) can also be used. Different thicknesses di of moderator can be used to optimize the neutron flux and give the highest therapeutic ratio.
  • the term“neutron generator or source” is intended to cover a wide range of devices for the generation of neutrons. The least expensive and most compact generator is the“fusion neutron generator” that produces neutrons by fusing isotopes of hydrogen (e.g. tritium and deuterium) by accelerating them together using modest acceleration energies. These fusion neutron generators are compact and relatively inexpensive compared to linear accelerators that can produce directed neutron beams.
  • the plasma ion source that is used to generate the neutrons at the cylindrical target. These are (1) the RF-driven plasma ion source using a loop RF antenna, (2) the microwave-driven electron cyclotron resonance (ECR) plasma ion source, (3) the RF-driven spiral antenna plasma ion source, (4) the multi-cusp plasma ion source and (5) the Penning diode plasma ion source. All plasma ion sources can be used to create deuterium or tritium ions for fast neutron generation.
  • ECR electron cyclotron resonance
  • Figs. 7A and 7B shows another embodiment of the invention which uses a cylindrical geometry to irradiate other organs and parts of patient 58, such as the liver 76.
  • Fig. 7 A is a cross sectional view of cylindrical neutron irradiation system 62 and
  • Fig. 7B is a perspective view of the same embodiment.
  • eight fast-neutron generators 68 surround a cylindrical moderator 46. These generators 68 all emit their fast neutrons at the surface of the moderator.
  • a cylindrical fast neutron reflector 44 surrounds the cylindrical moderator 46.
  • the cylindrical moderator 62 can be composed of well-known moderating materials such as 7 LiF, high density polyethylene (HDPE), and heavy water. These are shaped in a cylinder that surrounds the patient. The optimum thickness of the cylinder moderator for neutron capture purposes is dependent upon the material nuclear structure and density.
  • Fast neutron generator 68 is composed of a titanium target 52 and an ion source 50 as before.
  • the titanium targets are contiguous to the cylindrical moderator 46.
  • Ion beams 60 are accelerated using a DC high voltage (e.g. 100 kV) to the titanium target 52 where fast neutrons are produced from the DD fusion reaction.
  • the fast neutrons are emitted isotropically from the titanium targets 52 on the moderator, some moving out to the fast neutron reflector 44 and others inwardly to be moderated immediately to epithermal or thermal energies. Those reflected come back into the cylindrical moderator 46 where they are moderated to epithermal and thermal energies, making their way finally to the patient 58.
  • Cylindrical neutron irradiation system 62 permits uniform illumination of a section of the patient’s body (e.g. liver) as compared to the conventional planar neutron irradiation system.
  • the body In the case of the brain, the body itself acts as part of the moderation process, thermalizing epithermal neutrons coming in from cylindrical moderator 46.
  • the moderator can be made of deuterated polyethylene or heavy water (D2O) to maximize thermal neutron irradiation of the tumor near the surface of the body.
  • D2O deuterated polyethylene or heavy water
  • the moderator For deeper penetration of the neutrons one might make the moderator out of AIF3, producing epithermal neutrons. These would be optimum for reaching the liver and producing uniform illumination of that organ.
  • fast neutron sources with segmented moderators may be individually moved to achieve a uniform dose across the liver or other cancer site.
  • This geometry produces a uniform thermal neutron dose with a factor of between 1/10* and l/20 th of the required fast neutron yield and line-voltage input power of previous linear designs.
  • DD deuterium- deuterium
  • a segmented neutron irradiation system 70 in an embodiment of the invention is shown in Fig 8.
  • the exact shape of each moderator can vary and can be of other geometries.
  • Each generator and moderator pair can be moved independently of the others to achieve uniformity of the neutron flux across the liver, organ, or body part.
  • filler moderating material 72 In between the wedge-shaped moderators 74 more moderating material (“filler moderating material” 72) is inserted, forming a large single moderator.
  • The“filler” moderating material 72 can be heavy water or powered moderating materials such as AIF3.
  • Pie shaped fillers of moderating material can also be fitted into the spaces between the wedge-shaped moderator 74. Since neutrons scatter easily, there can be some space between the wedge-shaped moderators 74 and the pie shaped fillers without undue loss of neutron moderating efficiency.
  • each fast neutron generator 68 can be adjusted to achieve uniformity across the liver or body part.
  • the position and the neutron yield of the generator can be varied to achieve the desired radiation dose at a particular location in the patient’s body. Since the cancer can be located in any part of the body, this benefit can be particularly useful for optimizing the dose at the cancer site.
  • Fast neutrons are produced by the fast neutron generators 68 and enter the moderators 74 where they are elastically scattered by collisions with the moderator atoms’ nuclei, slowing them down after a few collisions to epithermal energies. As in the other embodiments, these epithermal neutrons enter the patient 58 and liver 76, wherein they are moderated further to thermal neutron energies.
  • the invention in various embodiments provides a uniform dose of thermal neutrons to the liver, organ or body part while minimizing fast neutron and gamma contributions.
  • the required number of fast neutrons (e.g. 2 x 10 11 n/s) to initiate this performance is again reduced compared to that (e.g. 2 x 10 13 n/s) needed for the planar neutron irradiation system of the prior art.
  • FIG. 9 Another embodiment of the segmented design is shown in Fig. 9.
  • the shape of the neutron irradiation system 78 is elliptical, with six sources of fast neutrons shown as distributed targets embedded in the inside elliptical moderator 96.
  • Fast neutrons 22 are emitted isotropically in all directions. Those fast neutrons 22 moving outwardly are reflected back (see arrow 48) by fast neutron reflector 44, while fast neutrons traveling inwardly 22 are moderated to epithermal energies and enter the liver 76, where further moderation of the neutrons to thermal energies occurs.
  • the inside elliptical moderator 96, outside elliptical moderator 98, reflector 44 and patient’s body 58 act together to moderate and concentrate the thermal neutrons into the patient’s liver 76.
  • the moderators and fast neutron sources 90, 92, 94 With a careful positioning of the moderators and fast neutron sources 90, 92, 94, a uniform dose can be achieved across the patient’s liver, and, with a boron drug administered to the tumor, an excellent therapeutic ratio can be achieved.
  • Elliptical neutron irradiation system 78 in Fig. 9 is a simplified cross-sectional view of the patient 58 inside the elliptical moderator 96.
  • This cross-section view is of a radial cut directly through the patent’ s torso and the moderator and fast neutron generator system.
  • the titanium targets are shown and not the ion sources.
  • six fast-neutron sources are represented by three flat titanium targets 90, 92, 94.
  • Other components e.g. plasma ion source
  • the wedge-shaped moderators 74 (used in Fig. 8) are also not shown in Fig. 9.
  • 94 are the sources of the fast neutrons and are arranged in an elliptical material 96 (e.g. AIF 3 , LiF).
  • an elliptical material 96 e.g. AIF 3 , LiF.
  • (MCNP5) transport code to determine how fast the neutrons were converted to thermal neutrons in the neutron irradiation system.
  • the fast neutron sources (titanium targets) are 2cm X 2cm in area, each producing 10" /N n/s, where N is the number of sources.
  • the human body 58 dimensions are 35.5cm along the major axis and 22.9cm along the minor axis.
  • the inner elliptical moderator 96 is made of 7 LiF and 10 cm thick, while the outer moderator 98 is made of AIF 3 and 40 cm thick.
  • the fast neutron reflector 44 is made of lead 50 cm thick. Boron- 10 concentration is 19.0 pg/g in the healthy tissue and 68.3 pg/g in the tumor.
  • the six sources are located in cms at: (-15,18.06,0) (-15,-18.06,0) (-17,17,0) (-17,-17,0) (0,15.85,0) (0,-15.85,0). These measurements are made along the axis of the liver 76 from the point (-15,0,0) to (-5,0,0).
  • the first two sources 90 are centered about the left edge of the liver shown in Fig. 9
  • the two sources 92 are centered about the edge of the body
  • the third two 94 are located above and below the origin.
  • the origin is shown in Fig. 9 as a small cross + at the center of the body in the plane of the liver.
  • Fig. 10 shows the therapeutic ratio for a large single dose, and the therapeutic ratio for multiple small doses (where the photon dose to healthy tissue is not included) plotted as a function of distance along the axis of the liver.
  • the photon dose can be neglected if there is some amount of time between doses.
  • Many of the body’s healthy cells can self-repair and recover between doses.
  • the expected therapeutic ratio is between these two curves when there is fractionation into multiple doses.
  • BPA was again used as the delivery drug with the concentration of boron in the tumor at 68.3 pg/gm and in the healthy tissue at 19 pg/gm.
  • Fig 11 indicates that the goal of having an extremely uniform dosage to the tumor has been achieved, with about ⁇ 6% variation along the x-dimension.
  • the calculated dose rates are comparable to those used for gamma radiotherapy, typically 1.8 to 2.0 Gy-equivalent per hour if we increase the total neutron yield to 2 x 10 11 to 3 x 10 11 n/s.
  • 2 x 10 11 to 3 x 10 n n/s it is possible to obtain a therapeutic ratio and uniform dosage to a tumor.
  • Approximately 10 to 20 treatments of 30 to 40 minutes would be required, with a good therapeutic ratio, uniformity of dosage, and the opportunity for healthy tissue repair between treatments.
  • planar neutron irradiation systems require high fast neutron yields to drive them.
  • a fast neutron source of 3xl0 13 n/s is needed to obtain realistic treatment time of ⁇ l-2 hours.
  • acceptable treatment times were obtained (30 to 72 minutes with single beam and 63 to 128 minutes with 3 beams of different direction). But these are impossible yields to achieve with realistic wall plug powers.
  • 50 to 100 kW for the hemispheric and cylindrical neutron irradiation systems it would take a minimum of 0.5 MW to achieve adequate yield for the planar geometry with a DT generator. These are high powers for clinics and hospitals.
  • the moderator can be made of deuterated polyethylene or heavy water (D2O) to maximize thermal neutron irradiation of the tumor near the surface of the body.
  • D2O deuterated polyethylene or heavy water
  • the moderator For deeper penetration of the neutrons one might make the moderator out of AIF3, producing epithermal neutrons. These would be optimum for reaching the liver and producing uniform illumination of that organ.
  • multiple modular generators may be encased in moderator material and may be arrayed to maximize thermal neutron flux at a cancer tumor location.
  • Fast 2.5 MeV neutrons must be slowed (moderated) to energies (usually epithermal) that will penetrate to the cancer site without too many neutrons being lost in their travel to the cancer via capture by healthy tissue.
  • These modular generators act as independent neutron sources and each may be optimized by adjustment of each individual beam’s energy, direction and intensity.
  • the modular generators can be arranged to fit a site in a particular subject’s component location and structure. This is true also for cancer tumor location.
  • the energy of the neutrons can also be adjusted by adding or subtracting moderator material. This can be done more easily than with a single beam LINAC or reactor, which usually has a fixed beamline that is integral to the neutron source. In the prior art some adjustment can be made, but the DD fusion generator in embodiments of the invention, being much smaller, can have more degrees of freedom in direction, intensity and moderation. This has an added benefit of aiding physicians in tailoring neutron radiation to the patient’ s cancer.
  • Modular generators in various embodiments of the present invention may also form and be part of the mechanical structure of a cancer irradiation system. This has an added benefit of moving the neutron sources as close as possible to the cancer site and the diseased body part, resulting in efficient use of the neutron source.
  • the neutrons are being emitted in a 4p solid angle from the modular generators, so the closer to cancer site, the more of the fast neutron flux is being utilized.
  • Linear accelerators (LINACs) which are somewhat collimated, are further from the cancer site and cannot provide this advantage.
  • the DD fusion sources in embodiments of the invention are less than one meter long and comprise compact microwave sources that can either be solid state microwave sources or small, inexpensive, single microwave oven magnetrons.
  • the accelerator structure in embodiments of the invention is compact and includes a pre-moderator 118 that adds only from 5-10 cm of High-Density Polyethylene (HDPE) or 15-20 cm of
  • PTFE polytetrafluoroethene Teflon to produce a first stage of neutron beam tailoring.
  • the pre-moderator in these embodiments is an integral part of each modular generator, as is taught below with reference to several figures.
  • other pre-moderator materials can be used such as AIF 3 , MgF 2 , 7 LiF, and Fluental (trade name).
  • the modular DD fusion generator 118 in embodiments of the present invention uses a small titanium target (e.g. a 5 cm diameter disk of titanium backed by water- cooled copper fins) to produce neutrons.
  • the target is supported directly on the pre moderator, which is an integral part of the apparatus in this application, termed a modular generator.
  • Linacs and other methods in the conventional arts use larger or toxic targets that require complex cooling and rotation.
  • the neutron source used by Neutron Therapeutics has a 2.6 MeV electrostatic proton accelerator and a rotating, solid lithium target for generating neutrons. In that prior-art process the Lithium becomes radioactive and toxic, and when exposed to air, it disintegrates.
  • This prior art source has a large target chamber housing a large Li disk which is rotated in a powerful 2.8 MeV proton beam produced by a large accelerator.
  • the Lithium wheel is roughly 2 meters in diameter and has been divided into pie-shaped sections that are removed by mechanical robotic means.
  • the Ti target is a relatively small diameter ( ⁇ 5 cm) and is typically attached with 6-8 screws to the pre-moderator block and is sealed to the block with a Viton“O” ring.
  • the Ti targets in embodiments of the invention can be easily manually removed and replaced. They also have a long lifetime and have been tested for over 4000 hours with no failures.
  • Nuclear reactors are large structures with a substantial amount of shielding (water and concrete) and cooling systems to maintain the hot reactor core. Reactors provide primarily thermal neutrons that must be raised up in energy using an energy multiplier, and then the neutron beam must be improved to IAEA standards to produce epithermal neutrons with minimal gamma radiation.
  • a goal for the moderator is to provide a neutron beam that has its energy clustered about 10 keV at the skin, in order to provide sufficient energy to penetrate a minimum of several centimeters into a human target while avoiding higher energies that are more damaging to human tissue.
  • High conversion to epithermal energies occurs in HD PE at a thickness of
  • modular generators are very important components.
  • the modular generator combines multiple functions that were separate functions in the prior art. These integrated functions include both neutron production and beam tailoring.
  • Fig. 12A is a perspective view of an individual modular generator 118 in an embodiment of the invention.
  • Fig. 12B is a cross section of the modular generatorl 18 of Fig. 12A taken along an axis of an acceleration chamber 100 for ion beam generation and containment, and at a right angle to the axis of a turbo vacuum pump 124 that is part of the modular generator 118.
  • Fig. 12C is a cross section of the modular generator 118 of Fig. 12A taken along the axis of the acceleration chamber 100, and along the axis of the turbo vacuum pump 124, at a right angle to the section of Fig. 12B.
  • Each modular generator 118 can operate independently of the other modular generators and each possesses all required components to generate neutrons. Further, the various modular generators may have pre-moderators shaped to engage other building blocks of a project, such as adjacent generators or spacing moderators, as is described in enabling detail below.
  • each modular generator 118 comprises a pre-moderator 108 that is made of material known to moderate energy of energetic neutrons.
  • the pre-moderator is a solid block of material, with a rather complicated shape for certain purposes.
  • Modular generator 118 has three key elements: (1) a deuterium ion source 102, (2) an acceleration chamber 100, through which deuterium ions may be accelerated, and (3) a titanium target 106 (shown in Figs. 12B and 12C) that is bombarded by the deuterium ions to produce high-energy neutrons.
  • the deuterium ion source 102 has an attached microwave source 160, and microwave slug tuners 172, connected by a cable 178. Deuterium gas is leaked slowly into a plasma ion chamber 174 at the upper end of the acceleration chamber, where microwave energy ionizes the gas, creating deuterium D+ ions.
  • the gas is ionized by microwave energy, and Deuterium (D+) ions are created and accelerated out through an ion extraction iris 138 into acceleration chamber 100, and through an electron suppression shroud 180 which deflects back-streaming electrons from being accelerated back into the plasma source, which could damage the apparatus. Electrons are being created by collisions of the D+ ions in the deuterium gas that are being created in the acceleration chamber.
  • D+ Deuterium
  • the deuterium ions are positively charged, and target 106 is negatively charged to a level of from 120 kV to 220 kV, and the D+ ions are strongly attracted to negatively biased target 106.
  • Acceleration chamber 100 is connected to a turbo vacuum pump 124 that provides a modest vacuum in one embodiment of about 10 6 Torr, minimizing scattering of the D + ions as they travel from the extraction iris 138 to the target 106.
  • Titanium target 106 is positioned in a primary electrically insulating well 181 at the bottom of the chamber embedded into the pre- moderator material, which may be UHMW, HDPE or Teflon, of the pre- moderator 108. There is further a secondary electrical insulating well 182 surrounding the primary electrical insulating well.
  • the surface of the moderator material in the primary and secondary electrical insulating wells may be seen as a corrugated insulator causing any surface charge to follow a curved path taken in any direction.
  • the purpose is to provide a very long surface path to prevent electrons from traveling from the target to acceleration chamber 100 wall or any grounded element, and to avoid surface electrical breakdown or flashover in that surface path.
  • the wells form an electrical insulating path. Additional corrugations or wells can be added to lengthen the path.
  • Pre- moderator 108 has a high voltage bus bar 122 and fluid cooling channels 120 to and from the target.
  • the high voltage is introduced via a high voltage receptacle 130 which is connected to the high voltage bus bar.
  • Pre-moderator 108 acts as a HV insulator and as a mechanical support for the target 106 at a high negative bias.
  • the pre-moderator 108 has metal cladding 140 at ground potential to minimize high voltage breakdown through the pre-moderator plastics.
  • Fig. 13 A illustrates an assembly of six modular generators 118, wherein pre moderators 108 are spaced apart by spacers 128 which are also made of moderator material.
  • Fig. 13B shows the arrangement of Fig. 13 A in perspective.
  • Fig. 13C shows the arrangement of Fig. 13B with one modular generator 118 removed from the assembly.
  • Fig. 13D is a more diagrammatic illustration showing an arrangement in which modular generators may be mounted on translation and rotation mechanisms to be positioned to maximum irradiation of a cancer site.
  • the modular generators in embodiments of the invention may be arranged in an array to form a complete and moveable system of irradiating neutron sources with pre moderators.
  • the modular generators may form a circle around a human torso or body part.
  • the modular generators can be moved into three dimensional arrays around the subject to maximize neutron flux to a cancer site 148 that may not be centered on a body part 146, illustrated as a human brain in Fig. 13D.
  • the modular generators may be moved to adapt to the shape and tumor location in order to maximize the dose to the cancer and to minimize the dose to the other body parts.
  • rotation 150 and translation 151 of the modular generator 118 can be achieved with electrical motors attached to the modular generator 118.
  • the pre-moderator also provides mechanical support, high voltage supply and cooling fluid transport to the titanium target.
  • Exemplary pre-moderator materials that may accomplish this are Teflon and HDPE. Both Teflon and HDPE are excellent high voltage dielectrics which can also support a HV bus bar 122 and water channels 120 to be used to transport HV and the cooling fluids to the Ti target, as shown in Fig. 12C. As shown in Figs.
  • a single generator 118 consists of an acceleration chamber 100, an ion source 102 emitting deuterium ions, a titanium target 106 and a pre-moderator 108.
  • Pre-moderator 108 also provides a fi nction of being a high voltage insulator for high voltage bus bar 122 that delivers high voltage (e.g. 80kV to 300 kV)) to titanium target 106, and a water channels 120 that deliver cooling fluid to the titanium target 106.
  • the high voltage is delivered from a high voltage power supply through a standard HV receptacle 130 to the bus bar 122 and then on to the titanium target 106, all of which are mounted in the pre-moderator 108.
  • the pre-moderator 108 performs seven functions: (1) moderation, (2) mechanical support of the titanium target, (3) cooling fluid transport to the target, (4) high voltage transport to the target, (5) minimum surface flashover, (6) and a portion of a high vacuum container (a wall) with no out gassing (7). These seven attributes permit a substantial reduction of distance and amount of material between the fast neutron source and the patient, thus helping to maintain a maximum neutron flux delivered to the patient.
  • FIGS 13A-D show how the generators may be arranged.
  • six modular generators 118 form a ring around a secondary moderator 112 and are part of a structure formed by secondary moderator 112, spacers 128, and pre-moderators 108.
  • Pre-moderators 108 and secondary moderator 112 provide the moderation lunction by slowing the neutrons down to epithermal energies (lunction #1).
  • These elements also form a mechanical support (lunction #2) for the entire generator and moderator system.
  • Secondary moderator 112 may also be a separate section attached directly to the modular generator just after the pre-moderator, each separate from the other instead of being in a ring 112 as in Fig. 13 A.
  • fluid transport (lunction #3) is supplied through channels 120, which delivers cooling fluid to target 106 to maintain the target at an acceptable operating temperature.
  • Each generator is supplied with a separate cooling fluid input and output, wherein cooling fluid is provided through a connector 132 shown in Figs. 12A- 12C.
  • the pre-moderator supplies fluid transport (function #4).
  • High voltage is delivered via high voltage bus 122, which passes through pre-moderator 108 (lunction 4, high voltage transport).
  • HDPE, UHMW and Teflon are excellent insulators and withstand high voltage flashover (lunction #6). All three may be used in vacuum systems without excessive out gassing and may help maintain the system vacuum (lunction #7). The achievement of these seven lunctions provides a very compact and flexible neutron source.
  • Secondary moderator 112 may comprise any one of or a combination of multiple moderator materials that optimize both the maximum flux and neutron energy for maximum dose to the cancer site. Selection (material, size and shape) may be varied depending on depth of the cancer in the subject and a desired dose at the cancer site.
  • the secondary moderator may be D2O (heavy water) for delivery of thermal neutrons to, for example, throat and neck cancers, or a combination of AIF3 and Teflon for delivery of epithermal neutrons to brain tumors.
  • the recommended levels of fast, thermal and gamma emission by IAEA are given in Table I.
  • IAEA p- Boronophenylalanine
  • FDA Food & Drug Administration
  • Delivery of higher boron concentrations to a cancer site may depend to some extent on newer drugs to be developed, and may permit lower power, less efficient neutron beams to be used. Since treatment time might also be faster, the neutron beam quality need not be as high.
  • DD fusion generators in embodiments of this invention have relatively low beam flux, thus permitting them to be used for cancer therapy.
  • multiple modular generators may be distributed around a secondary moderator surrounding a central chamber holding a subject for treatment, providing an alternative to a completely integrated multi-ion beam system, and may have particular benefits in some circumstances.
  • Benefits might include (1) an ability to quickly replace a single generator that has failed and needs repair; and (2) an ability to change alignment of the generators relative to one another, the moderator, and the subject.
  • alignment of the generators may optimize dose distribution and density of neutrons at a cancer site, while at the same time minimizing spurious radiation, such as gamma rays that might be emitted external to the apparatus, or into healthy tissue of the subject.
  • the modular generators in the embodiments of the present invention are particularly able to accomplish this by being positioned to maximize their flux at the cancer site.
  • each modular generator is placed as close to the patient’s body as practical to maximize flux at the cancer site, there is a more holistic problem.
  • a body part can now, in new implementations of the invention, be irradiated in all directions, and neutron intensity can be adjusted at each modular generator to achieve better flux and even more optimum neutron energy than with a single beam LINAC or a reactor.
  • the direction of each neutron beam can be adjusted by rotating and displacing each modular generator 118.
  • Each modular generator’s yield can be adjusted electronically by varying the accelerator voltage and the ion beam current. Since the moderator size is relatively small and compact compared to the prior art, the neutron spectrum of each modular generator 118 can be adjusted by the selection of different moderator materials and thicknesses.
  • the subject’s body is bombarded with neutrons from multiple directions.
  • the neutrons can come from all sides of the body part, which minimizes the amount of distance each beam has to transverse.
  • Unwanted neutrons striking the skin are now distributed over a larger area, reducing the skin dose of harmful components (e.g. gammas, and thermal and fast neutrons) per unit area. These components are simply delivered over a larger area of the skin. This permits adjustment of dose at the cancer site to be higher than that achieved with a single beam but with reduction of harmful components over a larger area of the skin.
  • harmful components e.g. gammas, and thermal and fast neutrons
  • multiple beam directions and an ability to adjust the neutron flux of each modular generator allow for optimum delivery to the cancer site while reducing harmful components. For example, if the cancer is located in the left lobe of the brain, the neutron flux to the tumor can be adjusted to deliver epithermal neutrons in the direction of that tumor. Since each modular generator neutron flux can be adjusted quickly by varying the accelerator’s high voltage or the ion beam current, and by translation and rotation, this can be done easily with delivery determined by a computer program. In the present invention, a control computer monitors the ion beam current, the acceleration voltage and the output neutron yield, which can be automatically adjusted.
  • Small modular generators in embodiments of the invention can make use of new boron dmg delivery methods for higher concentrations of boron to the cancer sites. Higher concentrations of boron lower the required neutron dose and require shorter delivery time. Higher boron concentrations to the cancer site permit use of neutron generators with lower neutron yield such as the modular DD fusion generators in embodiments of the present invention.
  • Each modular generator 118 is an independent device capable of producing neutrons independently of the other generators. This allows the total available power, P, to be distributed over N generators, resulting in the heat load being distributed safely without, for example damaging the titanium targets (unlike single target devices using lithium). In one example there are six modular generators, distributing total heat load per titanium target, since the number of neutrons per unit area is fixed by the ion beam power per unit target area.
  • Pre-moderators 108 can be shaped so that larger numbers of modular generators may be fitted around a subject to be treated. In the example shown by Fig. 13 A there are six generators arranged equally spaced around a common secondary moderator 112, the subject cavity 116 and the subject 134. Spacing blocks 128, composed of moderator material that may be the same as that of pre-moderator 108 (e.g.
  • Figs. 13A and 13B One embodiment of a system of modular generators is shown in Figs. 13A and 13B.
  • Fig. 13A a plane view of six modular neutron generators 118 fitting into the cylinder (or ring) is shown.
  • Fig.l3B a perspective view is shown.
  • the modular generators can also be arranged in other patterns to maximize the dose in particular locations in the subject’s body and deliver cancer therapy to selected body organs.
  • the modular generators may be moved by electric motors and mechanical means to optimized locations to provide the maximum dose to the cancer site and tumor profile as determined by boron bio-distribution test biopsy and pathological analysis, Positron Emission Computed Tomography (PET-CT), Computed Tomography (CT) or magnetic resonance imaging (MRI).
  • PET-CT Positron Emission Computed Tomography
  • CT Computed Tomography
  • MRI magnetic resonance imaging
  • moderator material between the modular generators.
  • the material can quickly position itself to the new location of the modular generators and also be a moderating material.
  • liquid moderator 156 can be used to surround the modular generators 118, acting as a secondary moderator.
  • the moderating material is shown between the movable modular generators.
  • the liquid is contained in an appropriate liquid container.
  • Liquids that also have good moderating properties can be used and are easily displaced by the modular generators when moving.
  • different grades of 3MTM FluorinertTM Electronic Liquid e.g. FC-40
  • FC-40 3MTM FluorinertTM Electronic Liquid
  • Teflon it contains primarily fluorine atoms, making it an excellent moderator, and no hydrogen.
  • Use of multiple modular generators in embodiments of the invention permits efficient use of modulator material, reducing size of moderator and shielding material and, thus, the reduction and size of the entire system. It also reduces the required flux density of fast neutrons by bringing the neutron sources closer to the patient and directing the limited number of neutrons to the cancer site in a more efficient fashion.
  • the subject’s body also becomes part of the equation of the moderating process. The fact that the neutrons are coming from multiple directions reduces local skin dose and localized body dose of healthy tissue. Rather than coming into the body at one location, the neutrons are coming from roughly 360 degrees around the body.
  • Moderation of fast neutrons in embodiments of the invention is a three-step process.
  • the pre-moderator 108 acts to reduce energy of the fast neutrons in as short a distance as practical with a minimal amount of gamma radiation produced in the process.
  • the pre-moderator also serves as a medium to (2) transport high voltage and (3) cooling fluid to a fast neutron production titanium target 106. Combining these three functions ((1) moderation, (2) fluid transport and (3) high voltage transport) reduces distance and the amount of material between the fast neutron source and the patient, helping to maintain a maximum neutron flux finally delivered to the patient.
  • Partially slowed neutrons can then pass into the secondary moderator 112 which continues the slowing process without undue production of gamma rays from, for example, hydrogen.
  • the selected moderator may be heavy water (D2O). Neutron energy reduction is continued by the D2O without the generation of ⁇ 2.2 MeV gammas that would occur if materials composed of hydrogen were used.
  • the neutrons need to be moderated to epithermal neutron energies.
  • the human body also acts as a partial, final moderator.
  • the epithermal energy neutrons are slowed iurther as they move through the body, and finally are slowed to thermal energies at the tumor site.
  • the moderation is a statistical and random process that reduces the neutron energy with a variation or spread of the neutron energies.
  • the process can also result in undesired gamma ray components (e.g. 2.2 MeV gammas from hydrogen capture of neutrons) which damage health cells.
  • selection of the moderator material depends at least in part upon the desired energy of the neutrons at the body’s skin to achieve maximum penetration to the cancer site while reducing (1) excess thermal energy components at the skin, (2) the cost and availability of the moderator material, and (3) harmful gamma ray components.
  • Each generator’s energy, yield, direction and moderation can be determined from moderation materials, the generator’s voltage and acceleration current. Unlike in the prior art, dimensions of the moderator and content may be quickly changed.
  • a liquid moderator e.g.
  • Fluorinert FC40 or a granular (e.g. AIF3) moderator may be used.
  • the modular generators are positioned in the liquid or granular moderator material, where they are free to move by mechanical means quickly between different cancer sites.
  • the moderators and shields are large, massive and usually fixed relative to a single beam reactor or linear accelerator. The patient is usually moved relative to the fixed neutron source.
  • liquid or granular moderator materials permits a more efficient reduction of fast neutrons to epithermal energies while minimizing thermals and fast neutrons.
  • Selection of the pre-moderator material is important for optimum neutron beam quality.
  • beam quality involves minimization of harm fill components of radiation that accompany the production of thermal neutrons at the cancer site but also the minimization of the fast and thermal neutrons at the skin surface.
  • gamma rays are produced and, depending upon the cancer site, fast neutrons must be converted to the right energy so that they penetrate the body and deliver thermal neutrons to the tumor site with minimal irradiation of healthy tissue.
  • Moderating the neutrons to thermal energy can result in the skin being damaged. Indeed, the thermal neutron dose to the skin can be larger than the dose to the tumor.
  • the body itself moderates and absorbs the neutrons as they penetrate the body. Selection of the moderator material requires materials that do not moderate the fast neutrons too quickly to thermal energies. Thermal neutrons can damage the skin, and if hydrogen atoms are present in the moderation process, then damaging gamma rays are also produced.
  • the human body also moderates and absorbs the neutrons. The desired required depth of penetration depends upon the location of the tumor in the body. Simulations show that penetration of thermal neutrons starting at the skin results in penetration depths of 3 to 5 cm before a large fraction of the neutrons are absorbed.
  • Teflon When used as a Pre-moderator, Teflon (PI ' LL) can satisfy 6 of the 7 lunctions listed above. Indeed, on several of the attributes Teflon excels. For example, since Teflon does not have atomic hydrogen, gamma production is avoided, whereas the use of HDPE does have hydrogen and, therefore maximizes the thermal neutron moderation with and added 2.2 MeV gamma ray component. Selection of HDPE as the pre-moderator material results in production of thermal neutrons in a short distance from the Ti target, whereas the use of Teflon results in a slower rate of neutron energy reduction from 2.5 MeV permitting the production of epithermal neutrons for deeper penetration into the human body and no 2.2 MeV gammas.
  • Teflon can have a minimum high voltage in which surface arcs (flashovers or surface discharges) momentarily short out the high voltage, and lead to damage to the Teflon surface and possibly damage to the high voltage power supply. This is primarily a materials problem and not a structural problem (shape of the accelerator and Teflon shape and structure).
  • Surface discharge along solid insulators in a vacuum in high voltage devices determines the maximum voltage between an anode and a cathode.
  • the voltage hold-off capability of a solid insulator in vacuum is usually less than that of a vacuum gap of similar dimensions.
  • Teflon or HDPE can hold charge like a battery or capacitor and then release it along the surface. This limits the use of plastics such as Teflon and HDPE as insulators and moderators inside the vacuum chamber of the neutron generator’s acceleration chamber 100.
  • the roughing method gives higher insulation strengths without time-consuming conditioning previously used. This provides a significant advantage and makes generators in embodiments of the present invention operational more quickly.
  • conditioning by the roughing process could take minutes or days. Below 1 MV m -1 , the conditioning process is relatively fast. Between 1 and 10 MV m -1 , the conditioning process takes longer. The best way to monitor how conditioning is going is to record the number of transient discharges (or sparks) per hour. At very high fields the arc rate might never get better than a few arcs per hour. A tolerable arc rate depends on the application. If no high voltage breakdown (arcs) can be tolerated, then the system must first be conditioned to a higher field, and then when the voltage is reduced to the operating level the arc rate drops almost to zero. For very high field strengths above 10 MV m -1 , it is very difficult to condition the electrodes to give an arc rate of zero. The electrode shape and material composition becomes very important at these field levels.
  • the human body acts as a moderator to reduce the epithermal neutrons to thermal energies at the cancer site.
  • the amount of neutron energy reduction by the human body depends at least in part upon the depth of the tumor in the body. This determines the maximum neutron flux for delivery to the patient.
  • the desired reduction of the neutron’ s energy will depend upon the depth of the tumor in the human body. For example, with throat and neck cancers the reduction of the neutron energy to thermal energies is desired for maximum dose to the cancer site. For small animal models, thermal energies are also desired.
  • the neutron energy can be at thermal energies.
  • epithermal neutrons 0.025 to 0.4 eV
  • pancreatic tumors are deep in the torso and require epithermal neutrons at entrance to the body to penetrate to the tumor. Moderation of the epithermal neutrons occurs as they pass though the body. Simulations in various embodiments show that there are materials at the right thicknesses, such as Teflon, 7 LiF and AP3 ⁇ 4, which produce the epithermal neutrons that penetrate the body and thermalize by the time they reach the depth of the tumor with a maximum neutron flux. In embodiments of the invention, this occurs while minimizing production of thermal neutrons at the skin. Shape of a Clinical Machine to match a human body
  • the shape of the patient’s chamber in a machine may be contoured to fit the human body part to maximize radiation to the cancer site. The shape depends upon the body part to be irradiated and the location of the tumor. As shown in Fig. 13D, for glioblastoma 148 (brain cancer), modular generators 118 may be arranged in a close ring around the head 146 that maximizes neutron flux to the cancer site 148 in the brain. The intensity of each generator can be varied to achieve maximum thermal neutrons to the tumor while minimizing the dose to healthy tissue. As discussed above, applications in embodiments of this invention permit control of the distance of each generator from the cancer site. The cancer site may be mapped using radiographic means (CT scans) and/or MRIs. A treatment planning protocol can then be determined for the optimum use of the clinical neutron source. The intensity of the neutrons coming from each neutron generator can then be varied and the location of each individual generator can be optimized.
  • CT scans radiographic means
  • a treatment planning protocol can then be determined for the
  • an improvement of the moderator surrounding the modular generators is to suspend or surround the modular generators with a liquid 156 that does not contain hydrogen (a gamma producing source), but has modest atomic-number atoms like Fluorine, Carbon or Nitrogen.
  • a liquid 156 that does not contain hydrogen (a gamma producing source), but has modest atomic-number atoms like Fluorine, Carbon or Nitrogen.
  • Various kinds of Fluorinert (tradename), FC-70 or FC-40, or FC3839 can be used.
  • the fluid may be put between the modular generators and by mechanical means each modular generator can move independently of the other generators to a certain extent. This fluid can also absorb some heat from modular generators.
  • an improvement of the moderator surrounding the modular generators is to suspend or surround the modular generators with a liquid 156 that does not contain hydrogen (a gamma producing source), but has modest atomic-number atoms like Fluorine, Carbon or Nitrogen.
  • a liquid 156 that does not contain hydrogen (a gamma producing source), but has modest atomic-number atoms like Fluorine, Carbon or Nitrogen.
  • Various kinds of Fluorinert (tradename), FC-70 or FC-40, or FC3839 can be used.
  • the fluid may be put between the modular generators and by mechanical means each modular generator can move independently of the other generators to a certain extent. This fluid can also absorb some heat from modular generators.
  • each stand-alone generator may be positioned and aligned to give a maximum flux and neutron distribution at the cancer site.
  • Each generator is small enough in size and weight that the generators may be mechanically moved and positioned so that optimum neutron flux at the cancer site is achieved, depending upon the cancer’s location and distribution.
  • the generators may be arranged around a moderator whose radial thickness is optimized to deliver a maximum thermal neutron flux to the cancer site.
  • the geometry can be circular or elliptical.
  • Fig 14A shows an on-axis view of an exemplary clinical neutron source using multiple modular generators 118 for BNCT of a human head.
  • This example uses eight modular generators 118 and assorted moderator materials coupled with reflecting and shielding material (e.g. graphite 144).
  • Secondary moderators (166 and 170) can be composed of one or more materials.
  • moderator spacing blocks 128 in one embodiment composed of the same material High Density Polyethylene (HDPE), Ultra High Molecular Weight polyethylene (UHMW), or (PTFE (Teflon)) as the secondary moderators. Blocks of these materials fit in between the modular generators and are adjacent to each generator’s pre-moderator. They act as mechanical spacers as well as moderator components.
  • the outside of this region, between and behind the modular generators 118, is filled with either graphite or lead 144 to serve as a neutron reflector and shield.
  • Fig.l4B also shows a side section view of the apparatus of Fig. 14A taken along a line through the top and bottom generators.
  • the cylindrical space 164 available for the patient’s head is 52 cm deep and 30 cm in diameter.
  • This space might be lined with 1 -mm of cadmium 162 to shield against too large a thermal neutron dose to the patent’s skin.
  • Shield 162 is also shown in Fig. 14A. In other embodiments this space may be lined with 6 LiF.
  • the reflector material graphite 144 is 30 cm thick in this example, the thickness of the Teflon 168, t, in front of the 2.5 MeV source is varied, and the portion 170 of the moderator is either 7 LiF or D2O. As t changes, the thickness of the A1/A1F 3 166 of the moderator changes, with all other dimensions remaining constant.
  • the target is embedded in the Teflon 168, UHMW or HDPE. Sources are titanium targets 106 being bombarded by deuterium ion beams 5.0 cm in diameter. Each target is emitting 4 x 10 10 neutron/sec. Eight modulator generatorsl 18 emit 3.2 X 10 11 n/s total emission.
  • a concentration of 10 B in the tumor and health tissue is known to be possible.
  • 10 B tumor concentration is assumed to be 50 ppm, while 10 B in healthy tissue is 15 ppm.
  • the relative biological effectiveness (RBE) for 10 B in tumor is 2.7, and in healthy tissue is 1.3.
  • Tumor and healthy tissue doses are calculated using the NRC and ICRP models for neutron RBE.
  • the material 7 LiF was the best performer and D2O was second best.
  • Fig. 15 shows the performance for moderators with different values for t in cm and either 7 LiF or D2O in the secondary moderator.
  • the ordinate R is the ratio of tumor dose at the origin to healthy tissue skin dose, and the tumor dose at the center of the brain assumed to be the site of the cancer.
  • 7 LiF outperforms D2O.
  • boron delivery agents for BNCT are an ongoing and challenging task of high priority.
  • a number of boron- 10 containing delivery agents have been prepared for potential use in BNCT.
  • BPA oronophenylalanine
  • BSH sodium borocaptate
  • BPA oronophenylalanine
  • BSH sodium borocaptate
  • PDX Patient-derived xenograft
  • PDX is created by transferring primary tumors from a patient into a mouse or small animal model. Tests of delivery and effectiveness of drugs to the cancer site can then be performed.
  • a small laboratory neutron source as in embodiments of this invention, is therefore valuable in the development and testing of new boron delivery drugs and their effectiveness in destroying the cancer site.
  • the secondary moderator may be a separate container of heavy water (D2O).
  • the secondary moderator volume can be reduced, and the compact modular generators can be moved close to it permitting the modular generators to be closer to the animal target.
  • the neutron flux at the cancer site is increased, and with proper selection of moderator material and size, will still be able to moderate the neutrons to IAEA standards.
  • the number of generators can be reduced while still maintaining a high thermal neutron flux at the cancer site.
  • Fig. 16A is a perspective view of a modular generator having such a rectangular pre-moderator 108, making it suitable for arrangements of four generators in a rectangular array, as shown in Fig. 16B.
  • the four modular generators are arranged around a secondary moderator 112, which in one embodiment may be a container of heavy water or granulated moderator material.
  • Fig. 16C is a cross section view of the arrangement of fig. 16B, taken along section line4 16C-16C of Fig. 16B.
  • the elements previously annotated for modular generators are reused in Figs. 16 A, B and C.
  • Fig. 16D is an exploded view where the four generators 118 are moved back from the small heavy water moderator 112.
  • Each generator 118 has a pre-moderator 108 with a fast neutron generator with a titanium target 106.
  • a deuterium ion beam is generated by a plasma ion source 102 and accelerated in an acceleration chamberlOO to the titanium target 106, where the DD lusion reaction occurs releasing fast 2.5 MeV neutrons.
  • the neutrons generated pass through a pre-moderator 108, where they are partially moderated to thermal neutron energies. They then pass into the moderator block 112 where they are farther moderated, reducing the energy of fast neutrons to thermal neutron energies.
  • the thermal neutrons then enter a cylindrical mouse chamber 114 where they enter the small animal 116.
  • the pre-moderator is designed to slow the fast neutrons to thermal neutrons by scattering the fast neutrons via collisions with the hydrogen in the HDPE or UHMW plastics.
  • the distance the 2.5 MeV neutrons have to traverse is approximately 3 to 5 cm, wherein approximately 50% of the neutrons lose enough of their energy to be classified as thermal neutrons.
  • These neutrons, containing both thermal and fast neutron components, can then travel into the moderator box 112, where they are lurther moderated by collisions with deuterium atoms. Roughly speaking, the HDPE with its hydrogen-atoms moderates the neutrons to thermal energies over a short distance; the thermalized neutrons then penetrate the cylindrical chamber 114 wherein they place the small animal 116.
  • the small animal model is used to test the delivery of boron to the cancer site.
  • high density polyethylene is optimum for producing the maximum flux of thermal neutrons.
  • HDPE high density polyethylene
  • a mouse is a small object, and penetration of thermal neutrons to the cancer site can easily be achieved.
  • Moderation of the fast neutrons to thermal energies is desired with minimum production of gamma radiation, which is harmful to the healthy cells.
  • hydrogen atoms are excellent at scattering fast neutrons, resulting in moderation of the neutrons to thermal energies in the shortest path length in the moderating material.
  • HDPE high-density polyethylene
  • UHMW plastic uses 5- 6 cm of high-density polyethylene (HDPE) or UHMW plastic to moderation of about 50% of 2.5 MeV neutrons to thermal energies. Further moderation of the neutrons by longer distances in the HDPE results in more fast neutrons being converted to thermal energies. However, this results in reduction of the total flux (n/cm 2 ) that is available since the neutrons are being emitted in a 4p solid angle. Hydrogen capture of neutrons produces high energy gamma radiation, which is destructive to both healthy and cancerous cells. Adding another moderator to farther thermalize the neutrons is accomplished by the use of heavy water (D2O).
  • D2O heavy water

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plasma & Fusion (AREA)
  • Pathology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)
  • Particle Accelerators (AREA)

Abstract

L'invention concerne un générateur de neutrons comprenant : un bloc pré-modérateur de matériau de modération, une chambre d'accélération, une pompe à vide évacuant la chambre d'accélération jusqu'à un vide modérément élevé, une chambre d'ions plasmatiques s'ouvrant dans la chambre d'accélération par l'intermédiaire d'un iris d'extraction d'ions, une source de gaz fournissant du deutérium gazeux à la chambre d'ions plasmatiques, une source d'énergie d'ondes hyperfréquence ionisant le gaz dans la chambre d'ions plasmatiques, un puits d'isolation primaire et un puits d'isolation secondaire s'étendant dans le bloc de pré-modérateur, un disque cible en titane refroidi à l'eau positionné au niveau d'une extrémité inférieure du puits d'isolation primaire, le disque cible étant polarisé à une tension en CC négative substantielle, et des surfaces de recouvrement, de type revêtement métallique, mises à la terre électriquement, du bloc pré-modérateur. Les ions extraits à travers l'iris d'extraction d'ions sont accélérés pour bombarder la cible en titane, produisant des neutrons énergétiques qui passent à travers le bloc modérateur et sont modérés par ce dernier.
PCT/US2019/057884 2018-10-24 2019-10-24 Source de neutrons pour thérapie par capture de neutrons WO2020101858A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP19885945.6A EP3870283A4 (fr) 2018-10-24 2019-10-24 Source de neutrons pour thérapie par capture de neutrons
EP22204108.9A EP4147750B1 (fr) 2018-10-24 2019-10-24 Source de neutrons pour thérapie par capture de neutrons
JP2021547657A JP7126733B2 (ja) 2018-10-24 2019-10-24 中性子捕捉療法のための中性子源

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862749875P 2018-10-24 2018-10-24
US62/749,875 2018-10-24
US16/662,523 2019-10-24
US16/662,523 US10737121B2 (en) 2011-06-27 2019-10-24 Neutron source for neutron capture therapy

Publications (1)

Publication Number Publication Date
WO2020101858A1 true WO2020101858A1 (fr) 2020-05-22

Family

ID=70731149

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2019/057884 WO2020101858A1 (fr) 2018-10-24 2019-10-24 Source de neutrons pour thérapie par capture de neutrons

Country Status (2)

Country Link
JP (1) JP7126733B2 (fr)
WO (1) WO2020101858A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116392731A (zh) * 2023-06-07 2023-07-07 四川中物积庆医疗科技有限公司 一种bnct中子慢化准直系统超热中子能量调整方法和系统

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7297341B1 (ja) * 2022-09-05 2023-06-26 株式会社J-Beam 中性子捕捉療法装置

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7177389B2 (en) * 2004-01-09 2007-02-13 Adelphi Technology X-ray tomography and laminography
US20140179978A1 (en) * 2011-06-27 2014-06-26 Adelphi Technology, Inc. Neutron Source for Neutron Capture Therapy
US20150216029A1 (en) * 2012-07-13 2015-07-30 Yagami Co., Ltd. Target for Neutron-Generating Device and Manufacturing Method Therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996017A (en) 1982-03-01 1991-02-26 Halliburton Logging Services Inc. Neutron generator tube
FR2636774A1 (fr) * 1988-08-26 1990-03-23 Sodern Dispositif de protection des tubes neutroniques
JP2006338945A (ja) 2005-05-31 2006-12-14 Mitsubishi Heavy Ind Ltd 中性子発生管
CN101699612B (zh) 2009-10-23 2012-02-29 东北师范大学 陶瓷填充式中子管
JP2017101930A (ja) 2015-11-30 2017-06-08 学校法人 新潟科学技術学園 診断装置、治療装置、及び、薬剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7177389B2 (en) * 2004-01-09 2007-02-13 Adelphi Technology X-ray tomography and laminography
US20140179978A1 (en) * 2011-06-27 2014-06-26 Adelphi Technology, Inc. Neutron Source for Neutron Capture Therapy
US20170216631A1 (en) * 2011-06-27 2017-08-03 Adelphi Technology, Inc. Neutron Source for Neutron Capture Therapy
US20150216029A1 (en) * 2012-07-13 2015-07-30 Yagami Co., Ltd. Target for Neutron-Generating Device and Manufacturing Method Therefor

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116392731A (zh) * 2023-06-07 2023-07-07 四川中物积庆医疗科技有限公司 一种bnct中子慢化准直系统超热中子能量调整方法和系统
CN116392731B (zh) * 2023-06-07 2023-08-25 四川中物积庆医疗科技有限公司 一种bnct中子慢化准直系统超热中子能量调整系统

Also Published As

Publication number Publication date
JP2022509361A (ja) 2022-01-20
JP7126733B2 (ja) 2022-08-29

Similar Documents

Publication Publication Date Title
US10603516B2 (en) Neutron source for neutron capture therapy
US10850130B2 (en) Neutron source for neutron capture therapy
Bayanov et al. Accelerator-based neutron source for the neutron-capture and fast neutron therapy at hospital
RU2720707C2 (ru) Элемент для формирования пучка, предназначенный для применения в нейтронозахватной терапии
EP3026673B1 (fr) Appareil de régulation de neutrons et appareil d'irradiation de neutrons
TWI686225B (zh) 中子捕獲治療系統
US5976066A (en) Neutron capture therapies
RU2745133C1 (ru) Система нейтрон-захватной терапии
JP7126733B2 (ja) 中性子捕捉療法のための中性子源
Bae et al. Advances of LINAC-based boron neutron capture therapy in Korea
US20240139546A1 (en) Neutron capture therapy system
Chernyaev et al. Radiation technology in medicine: Part 1. medical accelerators
EP4147750B1 (fr) Source de neutrons pour thérapie par capture de neutrons
EP4056229A1 (fr) Source de neutrons avec appareil de formation de faisceau pour le traitement du cancer
Kumada et al. Current development status of accelerator-based neutron source for boron neutron capture therapy
Yu et al. Measurements of the neutron yields from reaction (thick target) with incident energies from 1.885 to 2.0 MeV
Golubev et al. A compact neutron source for boron neutron capture therapy
Golshanian et al. 124Sb–Be photo-neutron source for BNCT: Is it possible?
Woods et al. Beam conditioning system for laser driven hadron therapy
Zhang et al. Developments in Neutron Sources for Boron Neutron Capture Therapy
Gu et al. Advance Particle Radiotherapy Technology–BNCT & PT from Ray System Corporation
JP2024524357A (ja) 中性子捕捉療法システム
Kadiri Shielding Upgrade and Beam Dump Design Analysis for a 40-MeV Electron Linear Accelerator at Idaho Accelerator Center
Bello Proposed Method for Measuring the LET of Radiotherapeutic Particle Beams
Chernyaeva et al. Part 1. Medical Accelerators

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19885945

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021547657

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019885945

Country of ref document: EP

Effective date: 20210525